159471-73-5

Usage

Uses

Used in Organic Synthesis:
2-(benzyloxy)-4-fluoroaniline is used as a key intermediate in the synthesis of various organic compounds. Its unique structure and reactivity allow for the creation of a wide range of biologically active molecules, contributing to the development of new chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(benzyloxy)-4-fluoroaniline is employed as a starting material for the development of fluorinated pharmaceuticals. The presence of the fluoro substituent often leads to improved pharmacokinetic properties, such as increased lipophilicity and metabolic stability, which can enhance the drug's efficacy and bioavailability.
Used in Drug Manufacturing:
2-(benzyloxy)-4-fluoroaniline is utilized as an important intermediate in the manufacture of various drugs. Its role in the synthesis of biologically active molecules makes it a crucial component in the production of a range of pharmaceuticals, ultimately contributing to the advancement of medical treatments.

Upstream product

• 446-36-6 5-fluoro-2-nitrophenol 
• 100-39-0 benzyl bromide 
• 129464-01-3 2-(benzyloxy)-4-fluoro-1-nitrobenzene 

Downstream Products

• 1609963-62-3 N-(2-benzyloxy-4-fluoro-phenyl)-7-bromo-5-methyl-quinazolin-4-amine 
• 1190603-61-2 C₂₄H₃₁FN₂O₄ 
• 159471-74-6 N-Ethyl-2-benzyloxy-4-fluoroaniline 
• 1609963-66-7 2-[(7-bromo-5-methylquinazolin-4-yl)amino]-5-fluorophenol 
• 1609963-67-8 7-bromo-N-[2-(cyclopropoxy)-4-fluorophenyl]-5-methylquinazolin-4-amine 
• 1609962-86-8 C₂₀H₂₂FN₅O₃S 
• 1609962-80-2 C₂₀H₂₁FN₄O₂S 
• 1609963-70-3 tert-butyl 4-[2-[[7-[[dimethyl(oxo)-λ⁶-sulfanylidene]amino]-5-methyl-quinazolin-4-yl]amino]-5-fluorophenoxy]isoxazolidine-2-carboxylate trifluoroacetic acid 
• 1609963-63-4 N-(2-benzyloxy-4-fluoro-phenyl)-7-[[dimethyl(oxo)-λ⁶-sulfanylidene]amino]-5-methyl-quinazolin-4-amine 
• 1609963-61-2 2-[[7-[[dimethyl(oxo)-λ⁶-sulfanylidene]amino]-5-methyl-quinazolin-4-yl]amino]-5-fluoro-phenol 

Relevant academic research and scientific papers

NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUND

There are provided compounds represented by the following general formula (I) or pharmaceutically acceptable salts of thereof, which have a superior monoacylglycerol acyltransferase 2 inhibitory action: wherein Ring A represents a partially saturated heteroaryl group, an aryl group or a heteroaryl group, RB represents a C4-18 alkyl group, a C3-8 cycloalkyl group, a partially saturated aryl group, an aryl group, or the following formula (II): wherein V represents the formula -CR11R12-, -CO-, -CO-O-, or -CO-NH-, W represents a single bond or a C1-3 alkylene group, and Ring B represents a C3-8 cycloalkyl group, a C3-8 cycloalkenyl group, a partially saturated heteroaryl group, a saturated heterocyclyl group, an aryl group, or a heteroaryl group, Y represents a nitrogen atom or the formula N+(RF), RF represents a C1-4 alkyl group, and m and n, which may be the same or different, each represent an integer of 0 or 1.

Cyclic sulfonamide herbicides

This invention relates to certain cyclic sulfonamides, their agriculturally-suitable salts and compositions, and methods of their use as general or selective preemergent or postemergent herbicides.